{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:57:00Z","timestamp":1785787020375,"version":"3.56.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270212"],"award-info":[{"award-number":["82270212"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y20220716"],"award-info":[{"award-number":["Y20220716"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Discipline Cluster of Oncology, Wenzhou Medical University","award":["z2-2023023"],"award-info":[{"award-number":["z2-2023023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04097-x","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T15:25:10Z","timestamp":1752593110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive analysis of exosome-related gene signature in multiple myeloma prognosis and immune microenvironment evaluation"],"prefix":"10.1007","volume":"74","author":[{"given":"Dong","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luning","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansen","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enqing","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanru","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouxiang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songfu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"4097_CR1","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s12253-015-9921-z","volume":"21","author":"MG Alexandrakis","year":"2015","unstructured":"Alexandrakis MG, Goulidaki N, Pappa CA, Boula A, Psarakis F, Neonakis I, Tsirakis G (2015) Interleukin-10 induces both plasma cell proliferation and angiogenesis in multiple myeloma. Pathol Oncol Res 21:929\u2013934. https:\/\/doi.org\/10.1007\/s12253-015-9921-z","journal-title":"Pathol Oncol Res"},{"key":"4097_CR2","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3238\/arztebl.2016.0470","volume":"113","author":"C Gerecke","year":"2016","unstructured":"Gerecke C, Fuhrmann S, Strifler S, Schmidt-Hieber M, Einsele H, Knop S (2016) The diagnosis and treatment of multiple myeloma. Dtsch Arztebl Int 113:470\u2013476. https:\/\/doi.org\/10.3238\/arztebl.2016.0470","journal-title":"Dtsch Arztebl Int"},{"key":"4097_CR3","doi-asserted-by":"publisher","unstructured":"Medical Masterclass C, Firth J (2019) Haematology: multiple myeloma. Clin Med (Lond). 19: 58\u201360. https:\/\/doi.org\/10.7861\/clinmedicine.19-1-58","DOI":"10.7861\/clinmedicine.19-1-58"},{"key":"4097_CR4","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1056\/NEJMoa1611750","volume":"376","author":"M Attal","year":"2017","unstructured":"Attal M, Lauwers-Cances V, Hulin C et al (2017) Lenalidomide, bortezomib, and dexamethasone with transplantation for myelomain. N Engl J Med 376:1311\u20131320. https:\/\/doi.org\/10.1056\/NEJMoa1611750","journal-title":"N Engl J Med"},{"key":"4097_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/20406207241237594","volume":"15","author":"S Yuan","year":"2024","unstructured":"Yuan S, Chen Y, Liu H (2024) Progress and prospect of ASCT combined with CAR-T therapy in the treatment of multiple myeloma. Ther Adv Hematol 15:20406207241237594. https:\/\/doi.org\/10.1177\/20406207241237594","journal-title":"Ther Adv Hematol"},{"key":"4097_CR6","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.jprot.2010.06.006","volume":"73","author":"S Mathivanan","year":"2010","unstructured":"Mathivanan S, Ji H, Simpson RJ (2010) Exosomes: extracellular organelles important in intercellular communication. J Proteomics 73:1907\u20131920. https:\/\/doi.org\/10.1016\/j.jprot.2010.06.006","journal-title":"J Proteomics"},{"key":"4097_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200:373\u2013383. https:\/\/doi.org\/10.1083\/jcb.201211138","journal-title":"J Cell Biol"},{"key":"4097_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbcan.2014.04.005","volume":"1846","author":"KB Johnsen","year":"2014","unstructured":"Johnsen KB, Gudbergsson JM, Skov MN, Pilgaard L, Moos T, Duroux M (2014) A comprehensive overview of exosomes as drug delivery vehicles \u2014 endogenous nanocarriers for targeted cancer therapy. Biochim et Biophys Acta (BBA) - Rev Cancer 1846:75\u201387. https:\/\/doi.org\/10.1016\/j.bbcan.2014.04.005","journal-title":"Biochim et Biophys Acta (BBA) - Rev Cancer"},{"key":"4097_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7150\/thno.21945","volume":"8","author":"C He","year":"2018","unstructured":"He C, Zheng S, Luo Y, Wang B (2018) Exosome theranostics: biology and translational medicine. Theranostics 8:237\u2013255. https:\/\/doi.org\/10.7150\/thno.21945","journal-title":"Theranostics"},{"key":"4097_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bbcan.2019.04.004","volume":"1871","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yu D (2019) Exosomes in cancer development, metastasis, and immunity. Biochim Biophys Acta 1871:455\u2013468. https:\/\/doi.org\/10.1016\/j.bbcan.2019.04.004","journal-title":"Biochim Biophys Acta"},{"key":"4097_CR11","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.1007\/s13277-015-3741-3","volume":"36","author":"A Caivano","year":"2015","unstructured":"Caivano A, Laurenzana I, De Luca L et al (2015) High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders. Tumour Biol 36:9739\u20139752. https:\/\/doi.org\/10.1007\/s13277-015-3741-3","journal-title":"Tumour Biol"},{"key":"4097_CR12","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M et al (2023) The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51:D638\u2013D646. https:\/\/doi.org\/10.1093\/nar\/gkac1000","journal-title":"Nucleic Acids Res"},{"key":"4097_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12:453\u2013457. https:\/\/doi.org\/10.1038\/nmeth.3337","journal-title":"Nat Methods"},{"key":"4097_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003323","volume":"17","author":"SA Danziger","year":"2020","unstructured":"Danziger SA, McConnell M, Gockley J et al (2020) Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: a cohort study of patients in the total therapy clinical trials. PLoS Med 17:e1003323. https:\/\/doi.org\/10.1371\/journal.pmed.1003323","journal-title":"PLoS Med"},{"key":"4097_CR15","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E et al (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612. https:\/\/doi.org\/10.1038\/ncomms3612","journal-title":"Nat Commun"},{"key":"4097_CR16","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D et al (2018) Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med 24:1550\u20131558. https:\/\/doi.org\/10.1038\/s41591-018-0136-1","journal-title":"Nat Med"},{"key":"4097_CR17","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15:e538\u2013e548. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"key":"4097_CR18","doi-asserted-by":"publisher","first-page":"C29","DOI":"10.1152\/ajpcell.00280.2019","volume":"318","author":"F Urabe","year":"2020","unstructured":"Urabe F, Kosaka N, Ito K, Kimura T, Egawa S, Ochiya T (2020) Extracellular vesicles as biomarkers and therapeutic targets for cancer. Am J Physiol Cell Physiol 318:C29\u2013C39. https:\/\/doi.org\/10.1152\/ajpcell.00280.2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"4097_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nri855","volume":"2","author":"C Thery","year":"2002","unstructured":"Thery C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2:569\u2013579. https:\/\/doi.org\/10.1038\/nri855","journal-title":"Nat Rev Immunol"},{"key":"4097_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/path.4712","volume":"239","author":"J Wang","year":"2016","unstructured":"Wang J, De Veirman K, Faict S, Frassanito MA, Ribatti D, Vacca A, Menu E (2016) Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression. J Pathol 239:162\u2013173. https:\/\/doi.org\/10.1002\/path.4712","journal-title":"J Pathol"},{"key":"4097_CR21","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.1038\/s41388-018-0359-0","volume":"37","author":"B Li","year":"2018","unstructured":"Li B, Xu H, Han H et al (2018) Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis. Oncogene 37:5508\u20135519. https:\/\/doi.org\/10.1038\/s41388-018-0359-0","journal-title":"Oncogene"},{"key":"4097_CR22","doi-asserted-by":"publisher","first-page":"13772","DOI":"10.18632\/oncotarget.3830","volume":"6","author":"L Raimondi","year":"2015","unstructured":"Raimondi L, De Luca A, Amodio N et al (2015) Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation. Oncotarget 6:13772\u201313789. https:\/\/doi.org\/10.18632\/oncotarget.3830","journal-title":"Oncotarget"},{"key":"4097_CR23","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1182\/blood-2016-09-742296","volume":"129","author":"S Manier","year":"2017","unstructured":"Manier S, Liu CJ, Avet-Loiseau H et al (2017) Prognostic role of circulating exosomal miRNAs in multiple myeloma. Blood 129:2429\u20132436. https:\/\/doi.org\/10.1182\/blood-2016-09-742296","journal-title":"Blood"},{"key":"4097_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13578-020-00521-0","volume":"11","author":"R Frazzi","year":"2021","unstructured":"Frazzi R (2021) BIRC3 and BIRC5: multi-faceted inhibitors in cancer. Cell Biosci 11:8. https:\/\/doi.org\/10.1186\/s13578-020-00521-0","journal-title":"Cell Biosci"},{"key":"4097_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122788","volume":"350","author":"G Siragusa","year":"2024","unstructured":"Siragusa G, Tomasello L, Giordano C, Pizzolanti G (2024) Survivin (BIRC5): implications in cancer therapy. Life Sci 350:122788. https:\/\/doi.org\/10.1016\/j.lfs.2024.122788","journal-title":"Life Sci"},{"key":"4097_CR26","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12885-022-09371-0","volume":"22","author":"A Faldt Beding","year":"2022","unstructured":"Faldt Beding A, Larsson P, Helou K, Einbeigi Z, Parris TZ (2022) Pan-cancer analysis identifies BIRC5 as a prognostic biomarker. BMC Cancer 22:322. https:\/\/doi.org\/10.1186\/s12885-022-09371-0","journal-title":"BMC Cancer"},{"key":"4097_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41598-020-79736-7","volume":"11","author":"L Xu","year":"2021","unstructured":"Xu L, Yu W, Xiao H, Lin K (2021) BIRC5 is a prognostic biomarker associated with tumor immune cell infiltration. Sci Rep 11:390. https:\/\/doi.org\/10.1038\/s41598-020-79736-7","journal-title":"Sci Rep"},{"key":"4097_CR28","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand A, Singer K, Koehl GE et al (2016) LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab 24:657\u2013671. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.011","journal-title":"Cell Metab"},{"key":"4097_CR29","unstructured":"Stefan Walenta MW, Michael Lehrke, Georg Schwickert, Kolbein Sundf\u00f8r, Einar K. Rofstad, and Wolfgang Mueller-Klieser (2000) High Lactate Levels Predict Likelihood of Metastases, Tumor Recurrence, and Restricted Patient Survival in Human Cervical Cancers."},{"key":"4097_CR30","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer K, Hoffmann P, Voelkl S et al (2007) Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109:3812\u20133819. https:\/\/doi.org\/10.1182\/blood-2006-07-035972","journal-title":"Blood"},{"key":"4097_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228879","author":"G Huang","year":"2020","unstructured":"Huang G, Li H, Zhang H (2020) Abnormal expression of mitochondrial ribosomal proteins and their encoding genes with cell apoptosis and diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21228879","journal-title":"Int J Mol Sci"},{"key":"4097_CR32","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1158\/0008-5472.CAN-17-3486","volume":"78","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Manjunath M, Zhang S, Chasman D, Roy S, Song JS (2018) Integrative genomic analysis predicts causative cis-regulatory mechanisms of the breast cancer-associated genetic variant rs4415084. Cancer Res 78:1579\u20131591. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-3486","journal-title":"Cancer Res"},{"key":"4097_CR33","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ajhg.2018.03.016","volume":"102","author":"X Guo","year":"2018","unstructured":"Guo X, Lin W, Bao J et al (2018) A comprehensive cis-eQTL analysis revealed target genes in breast cancer susceptibility loci identified in genome-wide association studies. Am J Hum Genet 102:890\u2013903. https:\/\/doi.org\/10.1016\/j.ajhg.2018.03.016","journal-title":"Am J Hum Genet"},{"key":"4097_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.2114","volume":"7","author":"N Shirani","year":"2024","unstructured":"Shirani N, Mahdi-Esferizi R, Eshraghi Samani R, Tahmasebian S, Yaghoobi H (2024) In silico identification and in vitro evaluation of MRPS30-DT lncRNA and MRPS30 gene expression in breast cancer. Cancer Rep 7:e2114. https:\/\/doi.org\/10.1002\/cnr2.2114","journal-title":"Cancer Rep"},{"key":"4097_CR35","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1002\/cam4.3907","volume":"10","author":"H Xu","year":"2021","unstructured":"Xu H, Zou R, Li F, Liu J, Luan N, Wang S, Zhu L (2021) MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer. Cancer Med 10:3655\u20133673. https:\/\/doi.org\/10.1002\/cam4.3907","journal-title":"Cancer Med"},{"key":"4097_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.656172","volume":"11","author":"Y Zeng","year":"2021","unstructured":"Zeng Y, Shi Y, Xu L, Zeng Y, Cui X, Wang Y, Yang N, Zhou F, Zhou Y (2021) Prognostic value and related regulatory networks of mrpl15 in non-small-cell lung cancer. Front Oncol 11:656172. https:\/\/doi.org\/10.3389\/fonc.2021.656172","journal-title":"Front Oncol"},{"key":"4097_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc.2017.104","volume":"18","author":"J Pelletier","year":"2018","unstructured":"Pelletier J, Thomas G, Volarevi\u0107 S (2018) Ribosome biogenesis in cancer: new players and therapeutic avenues. Nat Rev Cancer 18:51\u201363. https:\/\/doi.org\/10.1038\/nrc.2017.104","journal-title":"Nat Rev Cancer"},{"key":"4097_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cell.2005.07.034","volume":"123","author":"M Takagi","year":"2005","unstructured":"Takagi M, Absalon MJ, McLure KG, Kastan MB (2005) Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 123:49\u201363. https:\/\/doi.org\/10.1016\/j.cell.2005.07.034","journal-title":"Cell"},{"key":"4097_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10067-019-04751-7","volume":"39","author":"F Yang","year":"2020","unstructured":"Yang F, Zhai Z, Luo X, Luo G, Zhuang L, Zhang Y, Li Y, Sun E, He Y (2020) Bioinformatics identification of key candidate genes and pathways associated with systemic lupus erythematosus. Clin Rheumatol 39:425\u2013434. https:\/\/doi.org\/10.1007\/s10067-019-04751-7","journal-title":"Clin Rheumatol"},{"key":"4097_CR40","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13059-016-1104-z","volume":"17","author":"JC Guimaraes","year":"2016","unstructured":"Guimaraes JC, Zavolan M (2016) Patterns of ribosomal protein expression specify normal and malignant human cells. Genome Biol 17:236. https:\/\/doi.org\/10.1186\/s13059-016-1104-z","journal-title":"Genome Biol"},{"key":"4097_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","volume":"22","author":"M Maceyka","year":"2012","unstructured":"Maceyka M, Harikumar KB, Milstien S, Spiegel S (2012) Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 22:50\u201360. https:\/\/doi.org\/10.1016\/j.tcb.2011.09.003","journal-title":"Trends Cell Biol"},{"key":"4097_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12672-023-00611-8","volume":"14","author":"G Wang","year":"2023","unstructured":"Wang G, Zhang X, Zhou Z et al (2023) Sphingosine 1-phosphate receptor 2 promotes the onset and progression of non-alcoholic fatty liver disease-related hepatocellular carcinoma through the PI3K\/AKT\/mTOR pathway. Discov Oncol 14:4. https:\/\/doi.org\/10.1007\/s12672-023-00611-8","journal-title":"Discov Oncol"},{"key":"4097_CR43","doi-asserted-by":"publisher","first-page":"394632023117813","DOI":"10.1177\/03946320231178131","volume":"37","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wang H, Lu J, Lv Q, Yun B, Ge Z, Yan L (2023) Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma. Int J Immunopathol Pharmacol 37:3946320231178131. https:\/\/doi.org\/10.1177\/03946320231178131","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4097_CR44","doi-asserted-by":"publisher","first-page":"32841","DOI":"10.1074\/jbc.M305024200","volume":"278","author":"K Arikawa","year":"2003","unstructured":"Arikawa K, Takuwa N, Yamaguchi H, Sugimoto N, Kitayama J, Nagawa H, Takehara K, Takuwa Y (2003) Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity. J Biol Chem 278:32841\u201332851. https:\/\/doi.org\/10.1074\/jbc.M305024200","journal-title":"J Biol Chem"},{"key":"4097_CR45","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1158\/0008-5472.Can-04-2311","volume":"65","author":"D Lepley","year":"2005","unstructured":"Lepley D, Paik JH, Hla T, Ferrer F (2005) The G protein-coupled receptor S1P2 regulates Rho\/Rho kinase pathway to inhibit tumor cell migration. Cancer Res 65:3788\u20133795. https:\/\/doi.org\/10.1158\/0008-5472.Can-04-2311","journal-title":"Cancer Res"},{"key":"4097_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2024.101168","volume":"64","author":"SE Clarke","year":"2024","unstructured":"Clarke SE, Fuller KA, Erber WN (2024) Chromosomal defects in multiple myeloma. Blood Rev 64:101168","journal-title":"Blood Rev"},{"key":"4097_CR47","doi-asserted-by":"publisher","first-page":"888","DOI":"10.21037\/atm-22-3496","volume":"10","author":"HB Ye","year":"2022","unstructured":"Ye HB, Ma BJ, Meng GQ, Tao S, Wang Y, Chen Z, Zhao W, Ren BY, Ye Z (2022) Bioinformatics analysis of BIRC5 in human cancers. Ann Transl Med 10:888. https:\/\/doi.org\/10.21037\/atm-22-3496","journal-title":"Ann Transl Med"},{"key":"4097_CR48","doi-asserted-by":"publisher","first-page":"21735","DOI":"10.1038\/srep21735","volume":"6","author":"X Xiao","year":"2016","unstructured":"Xiao X, Huang X, Ye F et al (2016) The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer. Sci Rep 6:21735. https:\/\/doi.org\/10.1038\/srep21735","journal-title":"Sci Rep"},{"issue":"23","key":"4097_CR49","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1242\/jcs.113.23.4363","volume":"113","author":"J Zhao","year":"2000","unstructured":"Zhao J, Tenev T, Martins LM, Downward J, Lemoine NR (2000) The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J Cell Sci 113(23):4363\u20134371. https:\/\/doi.org\/10.1242\/jcs.113.23.4363","journal-title":"J Cell Sci"},{"key":"4097_CR50","doi-asserted-by":"publisher","first-page":"10875","DOI":"10.1007\/s11033-022-07788-1","volume":"49","author":"E Jamasbi","year":"2022","unstructured":"Jamasbi E, Hamelian M, Hossain MA, Varmira K (2022) The cell cycle, cancer development and therapy. Mol Biol Rep 49:10875\u201310883. https:\/\/doi.org\/10.1007\/s11033-022-07788-1","journal-title":"Mol Biol Rep"},{"key":"4097_CR51","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1038\/s41388-020-01639-8","volume":"40","author":"J Eniafe","year":"2021","unstructured":"Eniafe J, Jiang S (2021) The functional roles of TCA cycle metabolites in cancer. Oncogene 40:3351\u20133363. https:\/\/doi.org\/10.1038\/s41388-020-01639-8","journal-title":"Oncogene"},{"key":"4097_CR52","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.clon.2019.02.007","volume":"31","author":"EV Minten","year":"2019","unstructured":"Minten EV, Yu DS (2019) DNA repair: translation to the clinic. Clin Oncol (R Coll Radiol) 31:303\u2013310. https:\/\/doi.org\/10.1016\/j.clon.2019.02.007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"4097_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-3-319-60733-7_2","volume":"1007","author":"A Liakos","year":"2017","unstructured":"Liakos A, Lavigne MD, Fousteri M (2017) Nucleotide Excision Repair: From Neurodegeneration to Cancer. Adv Exp Med Biol 1007:17\u201339. https:\/\/doi.org\/10.1007\/978-3-319-60733-7_2","journal-title":"Adv Exp Med Biol"},{"key":"4097_CR54","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.dnarep.2014.03.030","volume":"19","author":"SS Wallace","year":"2014","unstructured":"Wallace SS (2014) Base excision repair: a critical player in many games. DNA Repair 19:14\u201326","journal-title":"DNA Repair"},{"key":"4097_CR55","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/moh.0000000000000259","volume":"23","author":"S Manier","year":"2016","unstructured":"Manier S, Kawano Y, Bianchi G, Roccaro AM, Ghobrial IM (2016) Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma. Curr Opin Hematol 23:426\u2013433. https:\/\/doi.org\/10.1097\/moh.0000000000000259","journal-title":"Curr Opin Hematol"},{"key":"4097_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112865","author":"A Allegra","year":"2021","unstructured":"Allegra A, Di Gioacchino M, Tonacci A, Petrarca C, Musolino C, Gangemi S (2021) Multiple myeloma cell-derived exosomes: implications on tumorigenesis, diagnosis, prognosis and therapeutic strategies. Cells. https:\/\/doi.org\/10.3390\/cells10112865","journal-title":"Cells"},{"key":"4097_CR57","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/85438","volume":"7","author":"J Wolfers","year":"2001","unstructured":"Wolfers J, Lozier A, Raposo G et al (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7:297\u2013303. https:\/\/doi.org\/10.1038\/85438","journal-title":"Nat Med"},{"key":"4097_CR58","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.4049\/jimmunol.1601694","volume":"198","author":"Y Kitai","year":"2017","unstructured":"Kitai Y, Kawasaki T, Sueyoshi T, Kobiyama K, Ishii KJ, Zou J, Akira S, Matsuda T, Kawai T (2017) DNA-containing exosomes derived from cancer cells treated with topotecan activate a STING-dependent pathway and reinforce antitumor immunity. J Immunol 198:1649\u20131659. https:\/\/doi.org\/10.4049\/jimmunol.1601694","journal-title":"J Immunol"},{"key":"4097_CR59","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fimmu.2013.00435","volume":"4","author":"AJ Tesone","year":"2013","unstructured":"Tesone AJ, Svoronos N, Allegrezza MJ, Conejo-Garcia JR (2013) Pathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancer. Front Immunol 4:435. https:\/\/doi.org\/10.3389\/fimmu.2013.00435","journal-title":"Front Immunol"},{"key":"4097_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121946","author":"QH Xie","year":"2022","unstructured":"Xie QH, Zheng JQ, Ding JY, Wu YF, Liu L, Yu ZL, Chen G (2022) Exosome-mediated immunosuppression in tumor microenvironments. Cells. https:\/\/doi.org\/10.3390\/cells11121946","journal-title":"Cells"},{"key":"4097_CR61","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13046-018-0815-2","volume":"37","author":"M Xiao","year":"2018","unstructured":"Xiao M, Zhang J, Chen W, Chen W (2018) M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma. J Exp Clin Cancer Res 37:143. https:\/\/doi.org\/10.1186\/s13046-018-0815-2","journal-title":"J Exp Clin Cancer Res"},{"key":"4097_CR62","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.4049\/jimmunol.176.3.1375","volume":"176","author":"C Liu","year":"2006","unstructured":"Liu C, Yu S, Zinn K et al (2006) Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol 176:1375\u20131385. https:\/\/doi.org\/10.4049\/jimmunol.176.3.1375","journal-title":"J Immunol"},{"key":"4097_CR63","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1158\/0008-5472.CAN-09-1688","volume":"70","author":"O Ashiru","year":"2010","unstructured":"Ashiru O, Boutet P, Fernandez-Messina L, Aguera-Gonzalez S, Skepper JN, Vales-Gomez M, Reyburn HT (2010) Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes. Cancer Res 70:481\u2013489. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1688","journal-title":"Cancer Res"},{"key":"4097_CR64","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.7534\/j.issn.1009-2137.2017.06.024","volume":"25","author":"WJ Xiong","year":"2017","unstructured":"Xiong WJ, Liu HX, Shi DY, Lou J, Zhang QL (2017) Effect of myeloma-derived exosomes on surface activating receptors of NK cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 25:1713\u20131717. https:\/\/doi.org\/10.7534\/j.issn.1009-2137.2017.06.024","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"4097_CR65","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1038\/s41388-018-0627-z","volume":"38","author":"L Li","year":"2019","unstructured":"Li L, Cao B, Liang X et al (2019) Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral \u03b3\u03b4 T cell equilibrium via tumor-derived exosomes. Oncogene 38:2830\u20132843. https:\/\/doi.org\/10.1038\/s41388-018-0627-z","journal-title":"Oncogene"},{"key":"4097_CR66","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41375-021-01301-6","volume":"36","author":"J Bae","year":"2022","unstructured":"Bae J, Accardi F, Hideshima T et al (2022) Targeting LAG3\/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma. Leukemia 36:138\u2013154. https:\/\/doi.org\/10.1038\/s41375-021-01301-6","journal-title":"Leukemia"},{"key":"4097_CR67","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/cyto.b.21279","volume":"90","author":"VE Muccio","year":"2016","unstructured":"Muccio VE, Saraci E, Gilestro M et al (2016) Multiple myeloma: new surface antigens for the characterization of plasma cells in the era of novel agents. Cytometry B Clin Cytom 90:81\u201390. https:\/\/doi.org\/10.1002\/cyto.b.21279","journal-title":"Cytometry B Clin Cytom"},{"key":"4097_CR68","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40364-024-00556-2","volume":"12","author":"A Andrzejczak","year":"2024","unstructured":"Andrzejczak A, Karabon L (2024) BTLA biology in cancer: from bench discoveries to clinical potentials. Biomark Res 12:8. https:\/\/doi.org\/10.1186\/s40364-024-00556-2","journal-title":"Biomark Res"},{"key":"4097_CR69","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1046\/j.1365-2141.2003.04260.x","volume":"121","author":"JE Guikema","year":"2003","unstructured":"Guikema JE, Hovenga S, Vellenga E et al (2003) CD27 is heterogeneously expressed in multiple myeloma: low CD27 expression in patients with high-risk disease. Br J Haematol 121:36\u201343. https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04260.x","journal-title":"Br J Haematol"},{"key":"4097_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.973836","volume":"12","author":"AG Solimando","year":"2022","unstructured":"Solimando AG, Malerba E, Leone P, Prete M, Terragna C, Cavo M, Racanelli V (2022) Drug resistance in multiple myeloma: soldiers and weapons in the bone marrow niche. Front Oncol 12:973836. https:\/\/doi.org\/10.3389\/fonc.2022.973836","journal-title":"Front Oncol"},{"key":"4097_CR71","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1158\/0008-5472.CAN-14-3400","volume":"75","author":"P Maiso","year":"2015","unstructured":"Maiso P, Huynh D, Moschetta M et al (2015) Metabolic signature identifies novel targets for drug resistance in multiple myeloma. Cancer Res 75:2071\u20132082. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3400","journal-title":"Cancer Res"},{"key":"4097_CR72","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1186\/s12885-019-6151-x","volume":"19","author":"J Abdi","year":"2019","unstructured":"Abdi J, Rastgoo N, Chen Y, Chen GA, Chang H (2019) Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells. BMC Cancer 19:975. https:\/\/doi.org\/10.1186\/s12885-019-6151-x","journal-title":"BMC Cancer"},{"key":"4097_CR73","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.leukres.2015.01.016","volume":"39","author":"M Tsubaki","year":"2015","unstructured":"Tsubaki M, Takeda T, Ogawa N et al (2015) Overexpression of survivin via activation of ERK1\/2, Akt, and NF-\u03baB plays a central role in vincristine resistance in multiple myeloma cells. Leuk Res 39:445\u2013452. https:\/\/doi.org\/10.1016\/j.leukres.2015.01.016","journal-title":"Leuk Res"},{"key":"4097_CR74","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.3324\/haematol.2019.221077","volume":"105","author":"M Colombo","year":"2020","unstructured":"Colombo M, Garavelli S, Mazzola M et al (2020) Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance. Haematologica 105:1925\u20131936. https:\/\/doi.org\/10.3324\/haematol.2019.221077","journal-title":"Haematologica"},{"key":"4097_CR75","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1182\/bloodadvances.2023011225","volume":"8","author":"RS Firestone","year":"2024","unstructured":"Firestone RS, McAvoy D, Shekarkhand T et al (2024) CD8 effector T cells enhance teclistamab response in BCMA-exposed and -na\u00efve multiple myeloma. Blood Adv 8:1600\u20131611. https:\/\/doi.org\/10.1182\/bloodadvances.2023011225","journal-title":"Blood Adv"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04097-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04097-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04097-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T11:04:26Z","timestamp":1757243066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04097-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":75,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["4097"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04097-x","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent was obtained from individuals agreeing to the publication of any potentially identifiable images or data included in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Ethics Committee at Wenzhou Medical University's First Affiliated Hospital authorized all of the study's procedures, which adhere to the Declaration of Helsinki.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"269"}}